APT Medical Valuation

Is 688617 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 688617 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 688617 (CN¥364.96) is trading above our estimate of fair value (CN¥106.49)

Significantly Below Fair Value: 688617 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 688617?

Key metric: As 688617 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 688617. This is calculated by dividing 688617's market cap by their current earnings.
What is 688617's PE Ratio?
PE Ratio53.7x
EarningsCN¥658.82m
Market CapCN¥35.38b

Price to Earnings Ratio vs Peers

How does 688617's PE Ratio compare to its peers?

The above table shows the PE ratio for 688617 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average67.8x
002223 Jiangsu Yuyue Medical Equipment & Supply
20.5x18.7%CN¥35.6b
688198 Beijing Balance Medical TechnologyLtd
155.9x41.1%CN¥16.1b
688301 iRay Technology
26.8x27.2%CN¥15.1b
300298 Sinocare
67.8x34.9%CN¥15.0b
688617 APT Medical
53.7x28.8%CN¥35.4b

Price-To-Earnings vs Peers: 688617 is good value based on its Price-To-Earnings Ratio (53.7x) compared to the peer average (67.8x).


Price to Earnings Ratio vs Industry

How does 688617's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
688617 53.7xIndustry Avg. 36.1xNo. of Companies15PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 688617 is expensive based on its Price-To-Earnings Ratio (53.7x) compared to the CN Medical Equipment industry average (36.1x).


Price to Earnings Ratio vs Fair Ratio

What is 688617's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

688617 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio53.7x
Fair PE Ratio35x

Price-To-Earnings vs Fair Ratio: 688617 is expensive based on its Price-To-Earnings Ratio (53.7x) compared to the estimated Fair Price-To-Earnings Ratio (35x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 688617 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥364.96
CN¥394.03
+8.0%
15.1%CN¥455.00CN¥313.10n/a3
Dec ’25CN¥362.62
CN¥394.03
+8.7%
15.1%CN¥455.00CN¥313.10n/a3
Nov ’25CN¥377.23
CN¥380.70
+0.9%
13.6%CN¥455.00CN¥313.10n/a4
Oct ’25CN¥409.39
CN¥380.70
-7.0%
13.6%CN¥455.00CN¥313.10n/a4
Sep ’25CN¥345.19
CN¥353.67
+2.5%
18.1%CN¥455.00CN¥286.90n/a4
Aug ’25CN¥323.67
CN¥342.86
+5.9%
13.9%CN¥411.72CN¥286.90n/a4
Jul ’25CN¥309.31
CN¥342.86
+10.8%
13.9%CN¥411.72CN¥286.90n/a4
Jun ’25CN¥340.00
CN¥342.86
+0.8%
13.9%CN¥411.72CN¥286.90n/a4
May ’25CN¥347.37
CN¥342.86
-1.3%
13.9%CN¥411.72CN¥286.90n/a4
Apr ’25CN¥301.27
CN¥294.25
-2.3%
4.6%CN¥313.10CN¥282.76n/a3
Mar ’25CN¥310.40
CN¥294.25
-5.2%
4.6%CN¥313.10CN¥282.76n/a3
Feb ’25CN¥269.10
CN¥294.25
+9.3%
4.6%CN¥313.10CN¥282.76n/a3
Jan ’25CN¥267.93
CN¥289.24
+8.0%
4.9%CN¥313.10CN¥276.95n/a4
Dec ’24CN¥260.50
CN¥289.24
+11.0%
4.9%CN¥313.10CN¥276.95CN¥362.624
Nov ’24CN¥244.50
CN¥281.28
+15.0%
1.1%CN¥284.14CN¥276.95CN¥377.233
Oct ’24CN¥264.03
CN¥281.28
+6.5%
1.1%CN¥284.14CN¥276.95CN¥409.393
Sep ’24CN¥244.42
CN¥285.88
+17.0%
3.1%CN¥297.93CN¥276.95CN¥345.193
Aug ’24CN¥228.29
CN¥285.88
+25.2%
3.1%CN¥297.93CN¥276.95CN¥323.673
Jul ’24CN¥257.76
CN¥285.88
+10.9%
3.1%CN¥297.93CN¥276.95CN¥309.313
Jun ’24CN¥250.23
CN¥285.88
+14.2%
3.1%CN¥297.93CN¥276.95CN¥340.003
May ’24CN¥251.38
CN¥285.42
+13.5%
2.9%CN¥296.55CN¥276.95CN¥347.373
Apr ’24CN¥243.90
CN¥268.84
+10.2%
8.4%CN¥296.55CN¥241.00CN¥301.273
Mar ’24CN¥243.02
CN¥268.84
+10.6%
8.4%CN¥296.55CN¥241.00CN¥310.403
Feb ’24CN¥245.84
CN¥261.94
+6.5%
5.8%CN¥275.86CN¥241.00CN¥269.103
Jan ’24CN¥211.68
CN¥254.98
+20.5%
5.5%CN¥268.97CN¥241.00CN¥267.932

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies